Arash Mostaghimi, MD, MPH, FAAD
SESSIONS
S065 Great Care for Common Conditions: Combining Evidence and Cost Effectiveness
Mar 10, 2025
•
1:00 PM - 4:00 PM
•
Valencia Ballroom D
U100 Medical Dermatology Potpourri: Challenges Faced and Lessons Learned
Mar 10, 2025
•
4:30 PM - 5:30 PM
•
W414C
DISCLOSURES
AbbVie – Consultant(Fees); Boehringer Ingelheim – Consultant (1099 relationship)(Fees); Eli Lilly and Company – Advisory Board(Fees), Investigator(Grants/Research Funding); Equillium, Inc. – Consultant(Fees); Hims – Advisory Board(Honoraria); Incyte Corporation – Investigator(Grants/Research Funding); Indomo – Consultant (1099 relationship)(Fees); Legacy Healthcare – Consultant (1099 relationship)(Fees); Olaplex – Advisory Board(Fees); Pelage Pharmaceuticals – Advisory Board(Fees); Pfizer Inc. – Advisory Board(Fees), Consultant(Fees); Q32 Bio Inc. – Consultant (1099 relationship)(Honoraria); Sun Pharmaceutical Industries Ltd. – Advisory Board(Fees);